Silver Book Fact

Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.

Johnston S, Rootenberg J, Katrak S, Smith W, et al. Effect of a U.S. National Institute of Health Programme of Clinical Trials in Public Health and Costs. The Lancet. 2006; 367: 1319-27. https://pubmed.ncbi.nlm.nih.gov/16631910/

Reference

Title
Effect of a U.S. National Institute of Health Programme of Clinical Trials in Public Health and Costs
Publication
The Lancet
Publication Date
2006
Authors
Johnston S, Rootenberg J, Katrak S, Smith W, et al.
Pages
1319-27
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Cardiovascular disease death rates
    Cardiovascular disease accounts for nearly 801,000 deaths in the US, or about 1 of every 3 deaths in the US.  
  • Because of the advent of imaging and noninvasive testing, Americans who are asymptomatic are being diagnosed with established cardiovascular disease.  
  • In 2005, 2,125 heart transplantations were performed in the U.S.  
  • Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…